Geographic and sociodemographic differences in cervical cancer screening modalities.

Cervical cancer screening recommendations for women aged 30–65 years include co-testing (high-risk human papillomavirus [hrHPV] with Pap testing) every five years or Pap testing alone every three years. Geographic variations of these different screening modalities across the United States have not been examined.